"Designing Growth Strategies is in our DNA"

Uterine Cancer Diagnostics Testing Market Size, Share And Global Trend By Type (Bloodtest, Endometrial biopsy, Imaging, Others), By End-user (Hospitals, Diagnostic centers, Cancer research centers, Others)And Geography Forecast Till 2022-2029

Region : Global | Report ID: FBI100582 | Status : Ongoing



In December 2018, Samsung Medison Co., Ltd. received the U.S Food and Drug Administration (FDA) approval for the company’s HS50/HS60 Diagnostic Ultrasound System used for transvaginal ultrasound scanning. Obesity, diabetes, Cowden syndrome, increased consumption of tamoxifen and sedentary lifestyle are some of the prominent causes for developing uterine cancer.  Women over age 50 years are more prone to uterine cancer. Endometrial biopsy is considered as the gold standard for diagnosis of endometrial cancer. According to the National Cancer Institute, as of 2019, there are an estimated 60,000 new cases of uterine cancer in the U.S. In some cases, uterine cancer leads to gestational trophoblastic disease.

Rising prevalence of uterine cancer is one of the significant drivers for the growth of global uterine cancer diagnostics testing market. According to the Canadian Cancer Society, in 2017, 7,300 women were diagnosed with uterine cancer in Canada alone. According to the Department of Health & Human Services, an estimated 11.0% of women between age 15-40 years are affected by endometriosis each year in the U.S. This combined with, rising prevalence of obesity as well as diabetes, growth in menstrual complications and rise in adoption of sedentary lifestyle is expected to further increase the prevalence of uterine cancer, which will eventually boost the demand for uterine cancer diagnostics testing during forecast period.

To gain extensive insights into the market, Request for Customization

However, complexities in biopsy procedure, high installations costs of imaging systems and lack of diagnostic infrastructure and shortage of healthcare resources including radiologists in emerging nations are restraining factors for the growth of global uterine diagnostics market.

Key Players Covered

Some of the major companies that are present in the global uterine cancer diagnostics testing market are F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, Abbott, Danaher, bioMérieux S. A., BD, and others.   




By Type

·         Blood test

·         Endometrial biopsy

·         Imaging

·         Others

By End-user

·         Hospitals

·         Diagnostic centers

·         Cancer research centers

·         Others

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


Among type, endometrial biopsy is anticipated to account for major share in the global uterine cancer diagnostics testing market owing to the higher adoption and cost associated with the technique.

Key Insights

Epidemiology of uterine cancer - for key countries, 2018

Market strategy of key players

Recent advancements in global uterine cancer diagnostics market

Key industry developments - mergers, acquisitions and partnerships, 2018

Regional Analysis

The global uterine cancer diagnostics testing market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is estimated to dominate the global uterine cancer diagnostics testing market in 2018 owing to the rise in prevalence of uterine cancer. According to the National Cancer Institute, in 2018, 63,230 new cases are diagnosed with uterine cancer in the U.S. alone. The incidence rate of uterine cancer is in the U.S., has increased by an estimated 1.3% from 2007-2017. Moreover, emphasis on early detection and prevention of cancer, improved accuracy in diagnostics due to technological enhancements in medical imaging techniques, rise in healthcare spending and various cancer awareness programs held by government is projected to be responsible for boosting the demand for global uterine cancer diagnostics testing market in the emerging countries of Asia Pacific.

Key Industry Developments

  • In November 2018, GE Medical Systems received U.S Food and Drug Administration approval for the company’s Versana Premier, an Ultrasonic Pulsed Doppler Imaging System for detection of uterine cancer.
  • In September 2018, GE Healthcare received U.S Food and Drug Administration approval for the company’s Voluson E6, Voluson E8, Voluson E10 pulsed Doppler imaging system.

  • Ongoing
  • 2021
  • 2018-2020


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.